Skip to content

XBI SPDR SERIES TRUST

Follow

S&P BIOTECH (fund)

807 managers (817 13F filers) reported a position in XBI shares at 2026-03-31, 131,295,147 shares in all. 94 filers opened a position and 97 filers sold out during the quarter.

Managers
807
13F filers
817
New
94
Added
251
Reduced
242
Sold out
97
Shares held by filers
131,295,147

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q1 2026

Filers in the available 13F reports with a share position at 2026-03-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Key Capital Management, INC7$894<0.01%new13F-HRTimeline
Grey Ledge Advisors, LLC7$893<0.01%013F-HRTimeline
Bogart Wealth, LLC6$770<0.01%013F-HRTimeline
Goodman Advisory Group, LLC6$766<0.01%013F-HRTimeline
SHP Wealth Management5$639<0.01%-25013F-HRTimeline
Horizon Investments, LLC4$511<0.01%+213F-HRTimeline
Sunbelt Securities, Inc.1$128<0.01%-9413F-HRTimeline